Product Reports Resources Pricing Login Book a demo

Medlumics

Health Tech & Medtech · Madrid, Spain · Founded 2009

MedLumics, founded in 2011, is a medical device startup focused on improving human living standards through advanced technology. The company operates in the biophotonics sector, which combines biology, medical science, physics, and photonic technology (the use of light to study and manipulate biological materials). MedLumics aims to transform scientific and technological advances in biophotonics into innovative, high-quality solutions for the global market. MedLumics primarily serves healthcare providers, including hospitals and medical research institutions, by offering cutting-edge medical devices that enhance diagnostic and therapeutic capabilities. The company's products are designed to generate, detect, process, visualize, and calculate light interactions with tissues, which are crucial for various clinical applications. These applications have seen significant growth and success in recent decades, largely due to advancements in the underlying technology. The business model of MedLumics revolves around research and development (R&D) and the commercialization of medical devices. The company invests heavily in R&D to stay at the forefront of biophotonics technology. Once a product is developed, it is brought to market and sold to healthcare providers. Revenue is generated through the sale of these medical devices, as well as through potential partnerships and collaborations with other companies and academic institutions. MedLumics places a strong emphasis on its employees, recognizing their talent as the most important resource. The company fosters an environment where employees can take initiative, fully utilize their talents, and feel a sense of pride and value. This focus on employee satisfaction and development is seen as a key factor in the company's growth and success. Keywords: Medical Devices, Biophotonics, Healthcare, Innovation, Technology, Diagnostics, Therapeutics, R&D, Global Market, Employee Talent.

Investors

11 investors on Medlumics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
European Innovation Council
Series A 5 investors entered at this stage
Ysios Capital
Criteria Venture Tech
Andera Partners
Innogest Capital
Seroba Life Sciences
Series B+ 5 investors entered at this stage
VI Partners
Asabys Partners
CDTI Innvierte
Kurma Partners
Criteria Bio Ventures

Global footprint

Where Medlumics has talent and traffic

Workforce by country
3 countries with
team presence
🇪🇸 Spain85.7%
🇺🇸 United States7.1%
🇨🇭 Switzerland7.1%
3 countries shown

Talent graph

The shape of Medlumics's talent

Dealroom maps Medlumics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

16 team members profilednamed & role-tagged by Dealroom
13 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Medlumics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Medlumics

An AI-synthesized read of the highest-engagement posts about Medlumics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medlumics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.